Resolution of iris neovascularization following chemoreduction of advanced retinoblastoma.
Shields
Carol L
CL
Ocular Oncology Service, Wills Eye Hospital, Philadelphia, PA 19107, USA. carol.shields@shieldsoncology.com
Sun
Hong
H
Manquez
Maria E
ME
Leahey
Ann
A
Meadows
Anna T
AT
Shields
Jerry A
JA
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D005260:Female; D005451:Fluorescein Angiography; D015355:Glaucoma, Neovascular / Q000473:pathology / Q000517:prevention & control; D006801:Humans; D007223:Infant; D007498:Iris / Q000098:blood supply*; D009389:Neovascularization, Pathologic / Q000175:diagnosis / Q000503:physiopathology*; D019572:Retinal Neoplasms / Q000188:drug therapy*; D012175:Retinoblastoma / Q000188:drug therapy* / Q000473:pathology; D014750:Vincristine / Q000627:therapeutic use
D014750:Vincristine; D005047:Etoposide; D016190:Carboplatin